ritonavir, Norvir (cont.)
Omudhome Ogbru, PharmD
Omudhome Ogbru, PharmD
Dr. Ogbru received his Doctorate in Pharmacy from the University of the Pacific School of Pharmacy in 1995. He completed a Pharmacy Practice Residency at the University of Arizona/University Medical Center in 1996. He was a Professor of Pharmacy Practice and a Regional Clerkship Coordinator for the University of the Pacific School of Pharmacy from 1996-99.
Medical and Pharmacy Editor:
Ritonavir may increase the blood concentration of lovastatin (Mevacor), simvastatin (Zocor), and atorvastatin (Lipitor). This may result in increased occurrence of myopathy (muscle pain) or rhabdomyolysis (muscle breakdown). Lovastatin and simvastatin should not be combined with ritonavir.
St. John's wort and rifampin (Rifadin) decrease the concentration of ritonavir in the body and this could reduce the effectiveness of ritonavir.
PREGNANCY: Use of ritonavir during pregnancy has not been adequately evaluated. To monitor outcomes of pregnant women that received ritonavir, an Antiretroviral Pregnancy Registry has been established. Physicians are encouraged to register patients by calling 1-800-258-4263.
NURSING MOTHERS: It is not known whether ritonavir is secreted in breast milk. Nevertheless, HIV-infected mothers should not breast-feed because of the potential risk of transmitting HIV to an infant that is not infected.
SIDE EFFECTS: The most serious side effects are liver failure, inflammation of the pancreas (pancreatitis), heart block, and severe allergic reactions. Ritonavir also may elevate blood glucose resulting in new onset diabetes. Fat redistribution, elevated triglycerides, and elevated cholesterol levels also occur. Patients with hemophilia may experience spontaneous bleeding. Immune reconstitution syndrome which is an inflammatory response to infection may occur in patients treated with combination antiretroviral therapy. Other side effects include diarrhea, nausea and vomiting, taste disturbance, abnormal skin sensations (burning, prickling and tingling), headache, weakness, and insomnia (difficulty sleeping).
Reference: FDA Prescribing Information
Last Editorial Review: 9/10/2012
Back to Medications Index
Get the latest health and medical information delivered direct to your inbox FREE!